Dr. Bedlack’s views on a new Edaravone study were quoted on Medscape January 17, 2022 by Dr. Richard Bedlack You can read it here: Medscape: https://www.medscape.com/viewarticle/966717#vp_1 ALZForum: https://www.alzforum.org/papers/safety-and-effectiveness-long-term-intravenous-administration-edaravone-treatment-patients#comment-43841